These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25884234)

  • 41. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
    Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of hypoxia-dependent factors on the progression of neuroblastoma.
    Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
    Pediatr Surg Int; 2016 Feb; 32(2):187-92. PubMed ID: 26510737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
    Coviello V; Marchi B; Sartini S; Quattrini L; Marini AM; Simorini F; Taliani S; Salerno S; Orlandi P; Fioravanti A; Desidero TD; Vullo D; Da Settimo F; Supuran CT; Bocci G; La Motta C
    J Med Chem; 2016 Jul; 59(13):6547-52. PubMed ID: 27305384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.
    Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
    J Enzyme Inhib Med Chem; 2016; 31(3):404-9. PubMed ID: 25884234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting carbonic anhydrase IX with small organic ligands.
    Wichert M; Krall N
    Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT; Winum JY
    Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
    Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs].
    Guo J; Li FR; Liu Y; Cheng MS
    Yao Xue Xue Bao; 2013 Nov; 48(11):1637-43. PubMed ID: 24475699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
    McDonald PC; Dedhar S
    Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.
    Winum JY; Colinas PA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1419-26. PubMed ID: 23199483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target.
    Potter C; Harris AL
    Cell Cycle; 2004 Feb; 3(2):164-7. PubMed ID: 14712082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis.
    Shamis SAK; Edwards J; McMillan DC
    Diagn Pathol; 2023 Apr; 18(1):46. PubMed ID: 37061698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation.
    Swietach P; Hulikova A; Vaughan-Jones RD; Harris AL
    Oncogene; 2010 Dec; 29(50):6509-21. PubMed ID: 20890298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.
    Tafreshi NK; Lloyd MC; Bui MM; Gillies RJ; Morse DL
    Subcell Biochem; 2014; 75():221-54. PubMed ID: 24146382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Carbonic anhydrase IX-based tumor imaging and therapy: a review].
    Lin J; Wang D; Liu J; Yang L; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):116-131. PubMed ID: 36738205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?
    Li J; Zhang G; Wang X; Li XF
    Future Oncol; 2015; 11(10):1531-41. PubMed ID: 25963430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation.
    Queen A; Bhutto HN; Yousuf M; Syed MA; Hassan MI
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):899-913. PubMed ID: 34998944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.